Top 50 Companies in Biopsy Devices Market in the World in 2025: Market Research Report (2024–2035)

Description

According to a research report published by Spherical Insights & Consulting, The Global Biopsy Devices Market Size is projected To Grow from USD 3.17 Billion in 2024 to USD 6.78 Billion by 2035, at a CAGR of 7.9 % during the forecast period 2025–2035. The biopsy devices market holds future opportunities in AI-guided diagnostics, minimally invasive procedures, rising cancer prevalence, and personalized medicine driving demand for precise, efficient, and patient-friendly tissue sampling solutions worldwide.

 

 

Introduction                                                             

The biopsy devices market refers to the segment of the medical devices industry that provides tools and technologies used to extract tissue samples for diagnostic examination, particularly to detect cancer and other abnormalities. These devices include needles, forceps, localization wires, and vacuum-assisted systems. The market is driven by several key factors: the rising global incidence of cancer and chronic diseases, increasing preference for minimally invasive diagnostic procedures, advancements in imaging and biopsy guidance technologies, and growing awareness regarding early disease detection. Additionally, the expansion of healthcare infrastructure and supportive government initiatives are further accelerating market growth.

 

Navigate Future Markets with Confidence: Insights from Spherical Insights LLP

The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.

 

Unlock exclusive market insights - Download the Brochure now and dive deeper into the future of the biopsy devices market.

 

Biopsy Devices Market Size & Statistics

• The market for biopsy devices was estimated to be worth USD 3.17 Billion in 2024.
• The market is going to expand at a CAGR of 7.9 % between 2025 and 2035.
• The Global Biopsy Devices Market Size is anticipated to reach USD 6.78 Billion by 2035.
• North America is expected to generate the highest demand during the forecast period in the Biopsy Devices Market.
• Asia Pacific is expected to grow the fastest during the forecast period in the Biopsy Devices Market.

 

 

 

Regional growth and demand                                     

Asia Pacific is expected to grow the fastest during the forecast period in the biopsy devices market. the Asia Pacific region is experiencing the quickest market expansion driven by advancements in healthcare infrastructure across several developing nations, growing patient demand, and the increasing incidence of cancer, which are expected to stimulate regional market growth.

 

North America is expected to generate the highest demand during the forecast period in the biopsy devices market. Due to the significant presence of the major market participants, which will maintain its leadership in the coming years. Additionally, the rising market penetration of technologically advanced equipment such as vacuum assisted biopsy systems, along with the growing demand for disposable devices, is expected to propel the growth of the regional market

 

Top Key Drivers & Biopsy Devices Trends

• Rising Incidence of Cancer and Chronic Diseases

One of the primary drivers of the biopsy devices market is the escalating global burden of cancer and other chronic conditions. With increasing awareness and improved screening programs, early diagnosis has become critical, thereby driving demand for accurate and minimally invasive biopsy procedures. Governments and healthcare organizations are also investing in public health campaigns and early detection programs, further boosting biopsy volumes. As cancer remains a leading cause of death worldwide, the need for reliable diagnostic tools such as core needle biopsies and vacuum-assisted devices continues to grow steadily across both developed and emerging markets.

 

• Advancements in Imaging and Biopsy Technologies

Technological innovations in imaging and biopsy guidance systems are significantly enhancing the precision and safety of tissue sampling procedures. Integration of advanced imaging techniques such as ultrasound, MRI, and CT with real-time navigation systems has improved the accuracy of biopsies, reducing complications and increasing diagnostic yield. Additionally, the development of smart, handheld, and robotic-assisted biopsy devices is streamlining procedures, making them quicker and less invasive. These advancements not only enhance clinical outcomes but also improve patient comfort and operational efficiency, making such technologies increasingly attractive to hospitals and diagnostic centers worldwide.

 

Empower your strategic planning:

Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the biopsy devices market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.

 

Top 5 Emerging Biopsy Startups Impacting the Healthcare Industry

1. EndoCore – Percutaneous Needle Biopsy (PNB)

Innovations in medical devices are revolutionizing endoscopy to enhance visibility within patients’ bodies. To further improve the effectiveness of biopsies, startups are driving advancements in the area of endoscopic cameras and their components. For example, cameras reduce the cost and invasiveness of percutaneous biopsies compared to other surgical methods. Irish startup EndoCore creates a unique percutaneous biopsy technology. The startup’s offering allows healthcare providers to consistently obtain intact tissue from patients through ultrasound-assisted endoscopic techniques. To accomplish this, a flexible needle instrument is utilized to acquire biopsies from the specific areas within the gastrointestinal tract.

 

2. BrainSpec – Magnetic Resonance Spectroscopy (MRS)

Grasping the size and location of tumors helps physicians develop the most effective strategy for biopsies. Brain tumors necessitate a particularly meticulous strategy for biopsies because of the intricate neural factors at play. Improvements in magnetic resonance spectroscopy technology enable healthcare providers to examine tumors closely, improve biopsy planning, and consequently reduce the likelihood of negative outcomes. The startup BrainSpec, located in the US, offers a software suite that integrates processing technology with an easy-to-use interface to utilize magnetic resonance spectroscopy. The process is secure, non-invasive, free of radiation, and compatible with all MRI machines. This approach allows healthcare providers to acquire enhanced images, monitor tissue metabolism, and evaluate the different biochemicals present in the brain.

 

3. DEBN – Prostate Biopsy

Ex-vivo biopsies assist oncologists in detecting prostate cancer early, thus enhancing patients' prognoses. Infectious complications frequently occur as a side effect of prostate biopsies. These consist of urinary tract infections, prostatitis, and potentially serious septic complications. By enhancing medical imaging techniques like ultrasound-guided biopsy imaging, startups can create solutions that increase the effectiveness and safety of biopsies. The Polish startup DEBN creates a unique, patent-pending biopsy needle that releases medication for prostate biopsies. The medical device from the startup includes a biopsy needle with a polymer coating and an anesthesia needle that delivers the medication straight to the prostate during the operation. Furthermore, the startup's approach manages the simultaneous use of antibiotics when necessary.

 

4. Aspire Medical Innovation – Bone Marrow Aspiration

Simple access, desire, biopsy, and cultivation of bone marrow are crucial in evaluating patients with uncommon genetic disorders like anemia and sickle-cell disease. Progress in stem cell therapy allows drug manufacturers to speed up the discovery and development of medications. Startups utilize these advancements to create solutions for bone marrow aspiration aimed at addressing different genetic abnormalities. The German startup Aspire Medical Innovation has developed Marrow Cellution, a system designed to enhance stem cell recovery while minimizing the risk of peripheral blood contamination. The startup's approach extracts stem cells in high quantities that are ready for use within 10 minutes. This procedure is less invasive compared to conventional bone marrow aspiration methods, minimizing patient trauma and morbidity.

 

5. Flomics – Cell-Free Nucleic Acid

The identification of circulating tumor ribonucleic acid (ctRNA) in the blood serves as an early indication of cancerous tumors, as they typically originate from a preexisting tumor. Liquid biopsies represent an innovative approach for identifying tumors, enhancing prospects for effective cancer therapy. Technological progress, including machine learning algorithms, enables startups to enhance sophisticated screening methods like liquid biopsies and other techniques that detect disease biomarkers from blood tests. Flomics, a Spanish startup, creates innovative blood-based diagnostic technologies for numerous complex illnesses. The startup employs a unique sequencing technology to examine circulating long ribonucleic acid (RNA) found in blood samples to precisely detect alterations in their patterns. Through deep learning algorithms, the startup allows healthcare providers to detect RNA alterations linked to disease conditions more quickly, affordably, and non-invasively.

 

Top 10 Companies Leading the Biopsy Devices Market

1. Argon Medical Devices, Inc.
2. B. Braun Melsungen AG
3. Becton Dickinson and Company (C.R. Bard, Inc.)
4. Boston Scientific Corporation
5. Cardinal Health, Inc.
6. Cook Medical, Inc.
7. Danaher Corporation (Leica Microsystem)
8. Fujifilm Holdings Corp.
9. Hologic, Inc.
10. Medtronic plc

 

1. Argon Medical Devices, Inc.

Headquarters: Plano, Texas, USA

Argon Medical Devices, Inc. is a U.S.-based manufacturer specializing in advanced medical products for interventional radiology, vascular surgery, cardiology, and oncology applications. With over five decades of experience, Argon focuses on percutaneous, image-guided technologies, offering a diverse range of biopsy needles, microcatheters, and drainage systems. Operating across Europe, Asia, and Africa, the company is recognized for its high standards in quality and procedural efficiency, particularly in biopsy and related interventional procedures.

 

2. B. Braun Melsungen AG

Headquarters: Melsungen, Germany

B. Braun Melsungen AG is a global leader in medical and pharmaceutical solutions, headquartered in Melsungen, Germany. Established in 1839, the company employs more than 63,000 professionals worldwide and delivers a comprehensive portfolio including biopsy instruments, surgical devices, and medical consumables. With operations in over 60 countries, B. Braun is known for its innovation, manufacturing excellence, and long-standing presence in hospitals and clinical settings globally.

 

3. Becton, Dickinson and Company (BD)

Headquarters: Franklin Lakes, New Jersey, USA

Becton, Dickinson and Company (BD) is a prominent global medical technology firm, headquartered in Franklin Lakes, New Jersey, and employing approximately 75,000 people worldwide. BD offers a wide array of precision biopsy solutions, including the EnCor Enspire™ vacuum-assisted breast biopsy system, Marquee disposable core biopsy devices, and TruGuide coaxial needles. The company continues to lead advancements in diagnostic accuracy and patient comfort through ongoing product innovation.

 

4. Boston Scientific Corporation

Headquarters: Marlborough, Massachusetts, USA

Boston Scientific Corporation is a leading developer of minimally invasive medical technologies, headquartered in Marlborough, Massachusetts. With a presence in over 100 countries and a workforce exceeding 53,000, the company provides a broad suite of biopsy products including pulmonary biopsy forceps, endoscopic biopsy systems like the iNod ultrasound-guided platform, and urological sampling devices such as Piranha forceps. Boston Scientific is dedicated to enhancing diagnostic precision and clinical outcomes through cutting-edge biopsy innovations.

 

5. Cardinal Health, Inc.

Headquarters: Dublin, Ohio, USA

Cardinal Health, Inc. is a diversified healthcare services and products company headquartered in Dublin, Ohio. The company plays a significant role in medical product manufacturing and pharmaceutical distribution, with operations in over 30 countries and partnerships with more than 75% of U.S. hospitals. Its biopsy product portfolio includes bone marrow biopsy and aspiration needles, tissue biopsy kits, and fine needle core biopsy (FNCB) solutions, delivered through its global medical segment.

 

Are you ready to discover more about the biopsy devices market?

The report provides an in-depth analysis of the leading companies operating in the global biopsy devices market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:

 

Company Profiles

1. Argon Medical Devices, Inc.
   • Business Overview
   • Company Snapshot
   • Products Overview
   • Company Market Share Analysis
   • Company Coverage Portfolio
   • Financial Analysis
   • Recent Developments
   • Merger and Acquisitions
   • SWOT Analysis
2. B. Braun Melsungen AG
3. Becton Dickinson and Company (C.R. Bard, Inc.)
4. Boston Scientific Corporation
5. Cardinal Health, Inc.
6. Cook Medical, Inc.
7. Danaher Corporation (Leica Microsystem)
8. Fujifilm Holdings Corp.
9. Hologic, Inc.
10. Medtronic plc

 

Conclusion

The global biopsy devices market is poised for significant growth, driven by rising cancer incidence, advancements in diagnostic technologies, and increasing demand for minimally invasive procedures. With strong adoption in North America and rapid expansion in Asia Pacific, the market is witnessing innovation through AI-guided tools and smart biopsy systems. Key players and emerging startups are contributing to the evolution of precise, patient-friendly solutions. As healthcare systems prioritize early detection and personalized treatment, biopsy technologies are becoming essential. The market outlook remains strong, supported by technological progress, expanding healthcare infrastructure, and a shift toward safer, faster, and more efficient diagnostic practices.

 

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter